Clinical Trial Update: Combined Single / Multiple Dose Escalation Study in Patients With Renal Anemia Due to CKD (Chronic Kidney Disease) [Phase 1]

View source ↗

Summary

This is a completed Phase 1 dose-escalation study of an investigational agent for renal anemia in patients with chronic kidney disease, sponsored by Bayer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Snippet

Sponsor: Bayer | Conditions: Anemia | Phase 1 | Status: COMPLETED